Remyelination & Regeneration targeted cellular therapies for neurodegenerative diseases. NeuroGenesis is a clinical stage cellular therapy company focusing on a proprietary subpopulation of bone marrow stem cells that are selected and enhanced to become remyelinating & regenerative biofactory cells. The platform NG CELL™️ technology is optimized to treat central nervous system diseases such as progressive […]
Location: United States, New York, Rochester
Investors 1
| Date | Name | Website |
| - | Excell Par... | excellny.c... |
Mentions in press and media 1
| Date | Title | Description |
| 24.04.2023 | NeuroGenesis Receives FDA Clearance for Phase IIb Study | On the heels of Multiple Sclerosis (MS) Awareness Month, NeuroGenesis officially announced that the U.S. Food and Drug Administration (FDA) has cleared the company’s Investigational New Drug (IND) to enroll patients in the U.S. for its Phas... |